| PERIOD ENDING | 25-Jan-09 | 26-Oct-08 | 27-Jul-08 | 27-Apr-08 | | Total Revenue | 130,224 | 216,405 | 289,912 | 304,105 | | Cost of Revenue | 145,050 | 199,501 | 253,165 | 264,199 | | | Gross Profit | (14,826) | 16,904 | 36,747 | 39,906 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 53,429 | 61,917 | 59,980 | 51,781 | | Non Recurring | (6,826) | 6,826 |
-
| (30,460) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (61,429) | (51,839) | (23,233) | 18,585 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,008 | 828 | 861 | 733 | | Earnings Before Interest And Taxes | (44,421) | (51,011) | (22,372) | 19,318 | | Interest Expense | 7,211 | 5,581 | 4,992 | 4,664 | | Income Before Tax | (51,632) | (56,592) | (27,364) | 14,654 | | Income Tax Expense | 56,848 | 196 | 406 | (7,660) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (108,480) | (56,788) | (27,770) | 22,314 | | | Non-recurring Events | | Discontinued Operations | (410) | 63 | (1,308) | (3,411) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (108,890) | (56,725) | (29,078) | 18,903 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($108,890) | ($56,725) | ($29,078) | $18,903 |
|
0.20% Nasdaq 
Income Statement
